Phibro Animal Health Corp - Company Profile
Powered by 
All the data and insights you need on Phibro Animal Health Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Phibro Animal Health Corp Strategy Report
- Understand Phibro Animal Health Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Phibro Animal Health Corp (Phibro), a subsidiary of BFI Co LLC, is an animal health and mineral nutrition company which develops, manufactures and markets an array of products for food animals including beef cattle, dairy cattle, poultry, swine and aquaculture. The company's products help prevent, control and treat diseases, enhance nutrition to help improve health and productivity of various animals. It also offers specific ingredients for use in the personal care, industrial chemical and chemical catalyst industries. The company sells animal health and mineral nutrition products directly to integrated poultry, swine and cattle integrators and through commercial animal feed manufacturers, wholesalers and distributors. Phibro is headquartered in Teaneck, New Jersey, the US.
Headquarters
United States of America
Address
300 Frank W. Burr Blvd., Suite 21, 65 Challenger Road, Teaneck, New Jersey, 07666
Website
www.pahc.com
Telephone
1 201 3297300
No of Employees
1,920
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PAHC (NASD)
Revenue (2023)
$977.9M
3.8%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-33.7%
(2023 vs 2022)
Market Cap*
$528.2M
Net Profit Margin (2023)
XYZ
-36.2%
(2023 vs 2022)
* As of and is in US$
Phibro Animal Health Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Animal Health and Nutrition: | AB20 |
| Antibiotics | Stafac |
| Antimicrobials | Aviax |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In October, Phibro Ethanol and Ingenza entered into a partnership to engineer a novel yeast strain. |
| 2022 | Contracts/Agreements | In June, the company and Rejuvenate Bio entered into an agreement for the development and commercialization of a gene therapy for Mitral Valve Disease in canines (dogs). |
| 2022 | Contracts/Agreements | In February, the company and Dyadic International, Inc entered into an exclusive license agreement for a Phibro targeted disease. |
Competitor Comparison
| Key Parameters | Phibro Animal Health Corp | Archer Daniels Midland Co | Eli Lilly and Co | Boehringer Ingelheim International GmbH | Zoetis Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Germany | United States of America |
| City | Teaneck | Chicago | Indianapolis | Ingelheim am Rhein | Parsippany |
| State/Province | New Jersey | Illinois | Indiana | Rheinland-Pfalz | New Jersey |
| No. of Employees | 1,920 | 40,213 | 43,000 | 53,000 | 14,100 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jack C. Bendheim | Chief Executive Officer; President; Chairman | Executive Board | 2014 | 76 |
| Larry L. Miller | Chief Operating Officer | Senior Management | 2016 | 59 |
| Richard G. Johnson | Chief Financial Officer - Interim | Senior Management | 2023 | - |
| Jonathan Bendheim | President - MACIE Region; Director; General Manager-Israel Operations | Executive Board | 2014 | 47 |
| Daniel M. Bendheim | Executive Vice President - Corporate Strategy; Director | Executive Board | 2014 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward